Effects of Loratadine, Cetirizine, and Terfenadine on Histamine-Induced Wheal and Erythema Responses in Normal Canine Skin

개 피부에서 Histamine에 의한 팽진과 발적에 대한 loratadine, cetirizine과 terfenadine의 억제효과

  • Jeong, A-Young (College of Veterinary Medicine, Kyungpook National University) ;
  • Jeong, Hyo-Hoon (College of Veterinary Medicine, Kyungpook National University) ;
  • Heo, Woo-Phil (College of Veterinary Medicine, Kyungpook National University) ;
  • Eom, Ki-Dong (College of Veterinary Medicine, Kyungpook National University) ;
  • Jang, Kawng-Ho (College of Veterinary Medicine, Kyungpook National University) ;
  • Oh, Tae-Ho (College of Veterinary Medicine, Kyungpook National University)
  • Published : 2002.06.01

Abstract

This crossover study was performed in order to compare the effects of cetirizine, loratadine, and terfenadine in canine skin. Five healthy dogs were used. Cetirizine 0.5 mg/kg, loratadine 5 mg/kg and terfenadine 5 mg/kg were administered orally 4 hours before the experiment. Erythema indices and wheal size were assessed by Hexameter ($MX^{\circledR}$ 18, CK, Germany) and skin reaction guide, respectively. Cetirizine-induced erythema inhibition was generally higher than other drugs and was significantly different from placebo. Cetirizine was superior to placebo at 3, 4, 5, 6, 7, and 8 minutes (p< 0.01). Cetirizine also was superior to placebo at 9 minutes (p< 0.05). Loratadine and terfenadine erythema inhibition were better than after placebo treatment from 4 to 9 minutes, but erythema index of terfenadine at 7 minutes was not observed probability of 95% and 99%. At 10 minutes, intradermal injection of the histamine caused a mean wheal dimension for placebo, cetirizine, loratadine and terfenadine, which were 13.25$\pm$0.75 mm,7.5$\pm$ 1.02 mm (53% reduction, p<0.007),6.2$\pm$0.58 mm(43% reduction, p <0.01), and 8.4 $\pm$0.67 mm(37% reduction, p< 0.05), respectively, comparing with placebo. Loratadine and cetirizine were good antihistamines for clinical therapy for atopic dermatitis in dog.

아토피성 피부염은 면역계재성 피부질환으로 소양증이 주요 증상이며 이의 치료가 필수적이다. 따라서 개에서 제2세대 항히스타민제의 임상적용을 위해 피부에 히스타민에 의해 유발된 팽진과 발적에 대한 loratadine, cetirizine과 terfenadine의억제 효과를 비교하였다. 3종의 항히스타민제는 대조군에 비해 매우 유의하게 발적반응을 억제하였으며(p<0.01) cetirizine이 다른 제제에 비해 높은 억제효과를 보였다. 3종의 항히스타민제는 팽진 반응을 억제하는 효과를 보였으며 loratadine의 억제효과가 일정하며 지속적이었다. 따라서 제 2세대 항히스타민제인 loratadine과 cetirizine은 개에서 아토피성 피부염의 소양증 치료에 적용할 수 있는 항히스타민제로 사료된다. 특히 스테로이드제제를 대체할 수 있는 치료효과를 보일 것으로 판단된다.

Keywords

References

  1. Drug Dev Res v.8 Oral antiallergic activity in Ascaris hypersensitive dogs: a study of known antihistamines and of the new compounds ramastine (R57959) and levocabastine (R50547) Awouters F;Vermeire J;smeyers F;vermote P;VanBeek R.;Niemgeers CJ https://doi.org/10.1002/ddr.430080112
  2. Clin Exp Dermatol v.24 Effects of acrovastine, loratadine and cetirizine of histamine-induced wheal and flare responses Bayramgurler D;Bilen N;Apaydyn R(et al) https://doi.org/10.1046/j.1365-2230.1999.00513.x
  3. Clin Exp Allergy v.28 no.SUP.6 Histamine-a major role in allergy? Bachert C
  4. Vet Clin N Am v.4 Atopic (allergic) dermatitis Chamberlain KW https://doi.org/10.1016/S0091-0279(74)50003-6
  5. J Allergy Clin Immunol v.83 Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction Charlesworth EN;Kagey-Sobotka A;Norman PS https://doi.org/10.1016/0091-6749(89)90104-8
  6. Br J Dermatol v.138 Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging Clough G;Bennett A;Church M https://doi.org/10.1046/j.1365-2133.1998.02217.x
  7. Allergy v.56 A randomized, double-blind, crossover comparison among cetirizine, levocetirizine and ucb28557 on histamine-induced cutaneous responses in healthy adult volunteers Devalia J;De Vos C;Hanotte F;Baltes E https://doi.org/10.1034/j.1398-9995.2001.00726.x
  8. Intrn Arch Allergy Appl Immunol v.82 Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine De Vos C;Joseph M;Leprevost C
  9. Am J Vet Res v.58 Effect of H₁-antihistamines on histmine release from dispersed canine cutaneous mast cells Garcia G;Demora F;Ferrer L;Puigdemont A
  10. Allergy v.50 A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24h in Health male subjects Grant JA;Danielson L;Rihoux JP;Devos C
  11. $4^{TH}$ world congress of veterinary dermatology clinical program proceedings Atopic dermatitis: clinical signs and diagnosis Halliwell REW
  12. Allergy v.412 Antiallergic activity of loratadine, a non-sedating antihistamine Kreutner W;Chapman RW;Gulbenkian A
  13. Arzneimittelforschung v.50 Preclinical pharmacology of desloratadine, a selective and nonsedationg histamine H1 receptor antagonist. I. Receptor selectivity, antihistaminic activity, and antiallergenic effects Kreutner W;Hey J;Anthes J;Barnett A;Young S;Tozzi S
  14. Arzneimittelforschung v.50 Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. Ⅱ. Lack of central nervous system and cardiovascular effects Kreutner W;Hey J;Chiu P;Barnett A
  15. Kiriks Current Veterinary Therapy XIII Antihistamines: Current Therapeutic Use. Mask GP
  16. J Allergy Clin Immumol v.86 The effects of antihistamines beyond H1 antagonism in allergic inflammation Massey WA;Lichtenstein LM https://doi.org/10.1016/S0091-6749(05)80247-7
  17. J Am Vet Med Assoc v.172 Canine allergic inhalant dermatitis: a review of 230 cases Nesbitt GH
  18. Allergic skin diseases of the dog and cat(2nd ed) Reedy LM;Miller WH;Willemse T
  19. The measurement of skin pH in normal dogs of different breeds Ruedisueli FL;Eastwood NJ;Gunn NK;Watson TDG
  20. J Am Anim Hosp Assoc v.17 Observations on canine atopy Scott DW
  21. Small Animal Dermatology(6th edition) Scott DW;Miller WH;Griffin CE